Home Tags DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

DCGI approves anti-COVID drug developed by DRDO for emergency use

Editor Desk - May 8, 2021 7:35 pm 0

DCGI approves anti-COVID drug developed by DRDO for emergency use By PIB Delhi An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab...

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune

Editor Desk - August 3, 2020 1:43 pm 0

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, PuneIndia’s Case Fatality Rate (CFR) further drops to 2.11%Total Recoveries more than 11.8 lakh by PIB Delhi The Drugs Controller General of India (DCGI)...

Adblocker detected! Please consider reading this notice.

We've detected that you are using AdBlock Plus or some other adblocking software which is preventing the page from fully loading.

We don't have any banner, Flash, animation, obnoxious sound, or popup ad. We do not implement these annoying types of ads!

We need money to operate the site, and almost all of it comes from our online advertising.

Please add https://www.ibgnews.com to your ad blocking whitelist or disable your adblocking software.

Tag: DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

Adblocker detected! Please consider reading this notice.